TORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of ...

Biogen’s Qalsody (tofersen) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the first ...

Experienced commercial leader to shape launch strategy and global market readiness for telitacicept and future pipeline ...

Differences in outcomes between patients with early Alzheimer’s disease who used lecanemab and matched controls increased ...

Measures intended to punish elite universities are inflicting collateral damage on the nation’s two-year colleges, which ...

Biotech company Amgen (NASDAQ:AMGN) will be reporting results this Tuesday after market hours. Here’s what to look for.

Marcus Evans announces the PharmaPack Summit 2025, an invitation-only event dedicated to the leaders defining the future of pharmaceutical packaging.

Sage Therapeutics, Inc. (Nasdaq: SAGE), today reported business highlights and financial results for the second quarter ended June 30, 2025.

Of the companies that reported their results last week, 18 beat analysts’ earnings forecasts, while 3 missed. On the revenue ...

Genetic testing company Myriad Genetics (NASDAQ:MYGN) will be announcing earnings results this Tuesday after market hours.

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

Disease severity, indicated by lupus nephritis, high CRP levels, and longer duration, negatively affects bone health in ...